Herbal Toxicity

Disease-a-Month

Volumn 55, Issue 10, 2009, Pages 592-641

  Tovar, Richard T ^a   Petzel, Renee M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ALPHA TOCOPHEROL; ARISTOLOCHIC ACID; BUFADIENOLIDE; CANTHARIDIN; DIGOXIN; DOCOSAHEXAENOIC ACID; EUCALYPTUS OIL; FERULIC ACID; FISH OIL; FLAVONOID; GINKGO BILOBA EXTRACT; GINSENOSIDE; GLYCYRRHIZIC ACID; GRAPE SEED EXTRACT; HERBACEOUS AGENT; ICOSAPENTAENOIC ACID; ISOSAFROLE; KAVA; MENTHOFURAN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PARACETAMOL; PLACEBO; PROANTHOCYANIDIN; PYRROLIZIDINE ALKALOID; SAFROLE; SALICIN; UNINDEXED DRUG; VALERIAN;

ABDOMINAL PAIN; ALZHEIMER DISEASE; AMENORRHEA; ANALGESIC ACTIVITY; ANGELICA SINENSIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY DISEASE; ARTHRITIS; ASTHMA; ATTENTION DEFICIT DISORDER; AYURVEDA; BEDTIME DOSAGE; BLEEDING; BLOOD TOXICITY; BRAIN DISEASE; BRAIN VASCULITIS; BRONCHITIS; CARCINOGENICITY; CARDIOTOXICITY; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CHRONIC FATIGUE SYNDROME; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLAUDICATION; CLINICAL TRIAL; COMA; CONFUSION; COUGHING; DEMENTIA; DEPRESSION; DIARRHEA; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG CONTAMINATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUODENUM ULCER; DYSLIPIDEMIA; ECCHYMOSIS; ENDOCRINE DISEASE; EPHEDRA SINICA; EPILEPSY; ESOPHAGUS VARICES; EXCITABILITY; FETOTOXICITY; FEVER; GARLIC; GASTROINTESTINAL SYMPTOM; GENITAL HERPES; GLYCYRRHIZA; HALLUCINATION; HEADACHE; HEART DISEASE; HEMATURIA; HERBAL MEDICINE; HUMAN; HYPERTENSION; INSOMNIA; ISCHEMIC HEART DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; LIVER FAILURE; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; LUNG TOXICITY; MEDICAL PRACTICE; MENTAL DISEASE; MOOD DISORDER; MOTOR DYSFUNCTION; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; NOSE CONGESTION; POLYPHARMACY; PORTAL HYPERTENSION; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; RESTLESSNESS; REVIEW; SEIZURE; SIDE EFFECT; SINUSITIS; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; STOMACH ULCER; STROKE; TERATOGENICITY; TINNITUS; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; VERTIGO; VOMITING; WEAKNESS;

ANIMALS; CARDIOVASCULAR SYSTEM; CLINICAL COMPETENCE; ENDOCRINE SYSTEM; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERB-DRUG INTERACTIONS; HERBAL MEDICINE; HUMANS; KIDNEY; LIVER; LUNG; MATERNAL-FETAL EXCHANGE; NERVOUS SYSTEM; PLANT EXTRACTS; PREGNANCY;

EID: 70349327791     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2009.05.001     Document Type: Review

References (223)

1. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. J Am Med Assoc 280 (1998) 1569-1575
2. Bent S., and Ko R. Commonly used herbal medicines in the United States: A review. Am J Med 116 (2004) 478-485
3. Pal S.K., and Yogeshwer S. Herbal medicine: Current status and the future. Asian Pac J Cancer Prev 4 (2003) 281-288
4. http://www.fda.gov. Accessed August 1, 2008.
5. Dietary supplement health and education Act of 1994, pub. L. Numbers 103-417. Stat 4325 (1994)
6. Bown D. The Herb Society of America New Encyclopedia of Herbs and Their Uses (2001), Dorling Kindersley, New York p 18
7. Williamson E. Drug interactions between herbal and prescription medicines. Drug Saf 26 (2003) 1075-1092
8. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 52 (2003) 1361-1371
9. http://www.FDA.gov. Accessed September 1, 2008.
10. Woolf A.D., Watson W.A., Smolinske S., et al. The severity of toxic reactions to Ephedra: Comparisons to other botanical products and national trends from 1993-2002. Clin Toxicol 43 (2003) 347-355
11. Public Health Security and Bioterrorism Preparedness and Response Act of 2002, Pub. L. No. 107-188, 116 Stat. 594 (January 23, 2002).
12. Winslow L., and Kroll D. Herbs as medicines. Arch Intern Med 158 (1998) 2192-2199
13. Miller L. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158 (1998) 2200-2211
14. Eisenberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the United States: Prevalence, costs, and patterns of use. N Engl J Med 328 (1993) 246-252
15. Qato D.M., Alexander G.C., Conti R.M., et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. J Am Med Assoc 300 (2008) 2867-2878
16. Garrard J., Harms S., Eberly L.E., et al. Variations in product choices of frequently purchased herbs: caveat emptor. Arch Intern Med 163 (2003) 2290-2295
17. Watkins R. Herbal therapeutics: The top 12 remedies. Emerg Med 9 (2002) 9-12
18. Milton D. Using alternative and complementary therapies in the emergency setting. J Emerg Nurs 24 (1998) 500-508
19. Moss T. Herbal medicine in the emergency department: A primer for toxicities and treatment. J Emerg Nurs 24 (1998) 509-513
20. Palmer M. Dietary supplements: "Natural" is not always safe. Emerg Med 9 (1998) 52-74
21. Boyer E. Issues in the management of dietary supplement use among hospitalized patients. J Med Toxicol 1 (2005) 30-34
22. Saad B., Azaizeh H., Abu-Hijleh G., et al. Safety of traditional Arab herbal medicine. ECAM 3 (2006) 433-439
23. Dasgupta A., and Bernard D.W. Herbal remedies. Effects on clinical laboratory tests. Arch Pathol Lab Med 130 (2006) 521-528
24. Dasgupta A., Biddle D.A., Wells A., et al. Positive and negative interference of Chinese medicine Chan Su in serum digoxin measurement: Elimination of interference by using a monoclonal chemilunimescent digoxin assay or monitoring free digoxin concentration. Am J Clin Pathol 114 (2000) 174-179
25. Chow L., Johnson M., and Wells A. Effect of the traditional Chinese medicines Chan Su, Lu-Shen-Wan, Dan Shen, and Asian ginseng on serum digoxin measurement by Tina-quant (Roche) and Synchron LX system (Beckman) digoxin immunoassays. J Clin Lab Anal 17 (2003) 22-27
26. Dasgupta A., Wu S., Actor J., et al. Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs. Am J Clin Pathol 119 (2003) 298-303
27. Dasgupta A., Tso G., and Wells A. Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by Digoxin III, a new digoxin immunoassay. J Clin Lab Anal 22 (2008) 295-301
28. Gowda R.M., Cohen R.A., and Khan I.A. Toad venom poisoning: Resemblance to digoxin toxicity and therapeutic implications. Heart 89 (2003) e14
29. Chi H.T., Hong D.Z., Hu W.H., et al. Prognostic implications of hyperkalemia in toad toxin intoxication. Hum Exp Toxicol 17 (1998) 343-346
30. Chen K.K., and Kovarikova A. Pharmacology and toxicology of toad venom. J Pharm Sci 56 (1967) 1535-1541
31. Lyttle T., Goldstein D., and Gartz J. Bufo toads and bufotenine: Fact and fiction surrounding an alleged psychedelic. J Psychoact Drugs 28 (1996) 267-290
32. Ko R.J. Safety of ethnic and imported herbal and dietary supplements. Clin Toxicol 44 (2006) 611-616
33. Huang W.F., Wen K.C., Hsiao M.L., et al. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 37 (1997) 344-350
34. Petty H.R., Fernando M., Kindzelskii A.L., et al. Identification of colchicine in placental blood from patients using herbal medicines. Chem Res Toxicol 14 (2001) 1254-1258
35. Li W., Fitzloff J.F., Farnsworth N.R., et al. Evaluation of commercial Ginkgo biloba dietary supplements for the presence of colchicine by high-performance liquid chromatography. Phytomedicine 9 (2002) 442-446
36. Ko R.J. Adulterants in Asian patent medicines. N Engl J Med 339 (1998) 847
37. Ko R., Wilson R.D., and Loscutoff S. PC-SPES. Urology 61 (2003) 1292
38. Holistic healing and natural alternative health care solutions. Miracle herbs: How to make and use herb preparations. http://www.healthynewage.com/makeherb.html Accessed December 26, 2008
39. Dr Standley herbal preparations. http://www.drstandley.com/supplements_herbal_preparations.shtml Accessed December 26, 2008
40. Koh H.L., and Woo S.O. Chinese proprietary medicine in Singapore: Regulatory control of toxic heavy metals and undeclared drugs. Drug Saf 23 (2000) 351-362
41. Ernst E., and Pittler M.H. Risks associated with herbal medicine products. Wien Med Wochenschr 152 (2002) 183-189
42. Russo S., Mastropasqua M., Mosetti M.A., et al. Low dose of liquorice can induce hypertension encephalopathy. Am J Nephrol 20 (2000) 145-148
43. Padiyara R.S., and Khan S.F. A review of commonly used herbal medicines. ICHP Keeposted 9 (2006) 22-36
44. Theoharides T.C. Sudden death of a healthy college student related to ephedrine toxicity from a Ma Huang containing drink. J Clin Psychopharmacol 17 (1997) 437-439
45. Ephedra. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
46. Food and Drug Administration. HHS: Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule. Fed Regist 69 (2004) 6787-6854
47. Haller C.A., and Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing Ephedra alkaloids. N Engl J Med 343 (2000) 1833-1838
48. Morgenstern L.B., Viscoli C.M., Kernan W.N., et al. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology 60 (2003) 132-135
49. Cohosh B. Natural medicines database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
50. Jones T.K., and Lawson B.M. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr 132 (1998) 550-552
51. Wright I.M. Neonatal effects of maternal consumption of blue cohosh. J Pediatr 132 (1999) 550-552
52. Ko R.J. A U.S. Perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc 67 (2004) 109-116
53. Aconite. Natural medicines database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
54. Lin C.C., Chan T.Y., and Deng J.F. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med 43 (2004) 574-579
55. But P.P., Tai Y.T., and Young K. Three fatal cases of herbal aconite poisoning. Vet Hum Toxicol 36 (1994) 212-215
56. Yeih D.F., Chiang F.T., and Huang S.K.S. Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart 84 (2000) E8
57. Lin T.J., Lu C.C., Chen K.W., et al. Outbreak of obstructive ventilatory impairment associated with consumption of Sauropus androgynus vegetable. Clin Toxicol 34 (1996) 1-8
58. Spyker D., Love L.A., and Brooks S.M. An outbreak of pulmonary poisoning. J Toxicol Clin Toxicol 34 (1996) 15-20
59. Aristolochia. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
60. Supplements D. Aristolochic acid: U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition. http://www.cfsan.fda.gov/∼dms/ds-bot.html Accessed: January 5, 2009
61. Nortier J.L., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 (2000) 1686-1692
62. Vanherweghem J.L., Depierreux M., Tielemans C., et al. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
63. Gingko. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
64. Bent S., Goldberg H., Padula A., et al. Spontaneous bleeding associated with ginkgo biloba: A case report and systematic review of the literature. J Gen Intern Med 20 (2005) 657-661
65. Kohler S., Funk P., Kieser M., et al. Influence of a 7 day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: A randomized, placebo controlled double-blind study in health volunteers. Blood Coagul Fibrinolysis 15 (2004) 303-309
66. DeKosky S.T., Williamson J.D., Fitzpatrick A.L., et al. Ginkgo biloba for prevention of dementia: A randomized controlled trial. J Am Med Assoc 300 (2008) 2253-2262
67. Dodge H.H., Zitzelberger T., Oken B.S., et al. A randomized placebo-controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 70 (2008) 1809-1817
68. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 352 (1998) 36
69. Meisel C., Johne A., and Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 167 (2003) 367
70. Bent S., Goldberg H., Padula A., et al. Spontaneous bleeding associated with Ginkgo biloba. A case report and systematic review of the literature. J Gen Intern Med 20 (2005) 657-661
71. Rowin J., and Lewis S.L. Spontaneous bilateral subdural hematomas with chronic gingko biloba ingestion. Neurology 46 (1996) 1775-1776
72. Siegers C.P. Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 6 (1999) 281-283
73. Morgenstern C., and Biermann E. The efficacy of ginkgo special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther 40 (2002) 188-197
74. Pennisi R.S. Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba. Med J Aust 184 (2006) 583-584
75. Davydov L., and Stirling A.L. Stevens-Johnson syndrome with Ginkgo biloba. J Herb Pharmacother 1 (2001) 65-69
76. Haller C. Clinical approach to adverse effects and interactions related to herbal and dietary supplements. Clin Toxicol 44 (2006) 605-610
77. Dong quai. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
78. Monograph. Angelica sinensis (Dong quai). Altern Med Rev 9 (2004) 429-433
79. Nambiar S., Schwartz R.H., Constantino A., et al. Hypertension in mother and baby linked to ingestion of Chinese herbal medicine. West J Med 171 (1999) 152
80. Lau C.B.S., Ho T.C.Y., Chan T.W.L., et al. Use of dong quai (Angelica sinensis) to treat peri- and postmenopausal symptoms in women with breast cancer: Is it appropriate?. Menopause 12 (2005) 734-740
81. Amato P., Christophe S., and Mellon P.L. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9 (2002) 145-150
82. Page II R.L., and Lawrence J.D. Potentiation of warfarin by dong quai. Pharmacotherapy 19 (1999) 870-876
83. Corrigan J.J., and Marcus F.L. Coagulopathy associated with vitamin E ingestion. J Am Med Assoc 230 (1974) 1300-1301
84. Heck A.M., DeWitt B.A., Lukes A.L., et al. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 57 (2000) 1221-1227
85. Fiebich B.L., and Appel K. Anti-inflammatory effects of willow bark extract. Clin Pharmacol Ther 74 (2003) 96
86. Schmid B., Kotter I., and Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J Clin Pharmacol 57 (2001) 387-391
87. Bark W. Natural medicines database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
88. Biegert C., Wagner I., Ludtke R., et al. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: Results of 2 randomized double-blind controlled trials. J Rheumatol 31 (2004) 2121-2130
89. Chrubasik S., Eisenberg E., Balan E., et al. Treatment of low back pain exacerbations with willow bark extract: A randomized double-blind study. Am J Med 109 (2000) 9-14
90. Food and Drug Administration, HHS: Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's syndrome warning. Final rule. Fed Regist 68 (2003) 18861-18869
91. Grape. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
92. Freedman J.E., Parker C., Li L., et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103 (2001) 2792-2798
93. Nuttall S.L., Kendall M.J., Bombardelli E., et al. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther 23 (1998) 385-389
94. Bernstein D.I., Bernstein C.K., Deng C., et al. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: A pilot study. Ann Allerg Asthma Immunol 88 (2002) 272-278
95. Escher M., Desmeules J., Giostra E., et al. Hepatitis associated with kava, a herbal remedy. Br J Med 322 (2001) 139
96. Escher M., Desmeules J., Giostra E., et al. Drug points: Hepatitis associated with kava, a herbal remedy for anxiety. BMJ 322 (2001) 139
97. Russmann S., Lauterberg B.H., and Hebling A. Kava hepatotoxicity. Ann Intern Med 135 (2001) 68
98. Liver toxicity with kava. Pharmacist's Lett/Prescriber's Lett 18 (2001) 180115
99. Centers for Disease Control and Prevention (CDC). Hepatic toxicity possibly associated with kava-containing products-United States, Germany, and Switzerland, 1999-2002. MMWR Morb Mortal Wkly Rep 51 (2002) 1065-1067
100. Kava. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
101. Neff G.W., Reddy R., Durazo F.A., et al. Letters to the editor: Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma Huang or usnic acid. J Hepatol 41 (2004) 1061-1067
102. Borum M.L. Abstract: Fulminant exacerbation of autoimmune hepatitis following the use of Ma Huang. Am J Gastroenterol 95 (2000) 2566
103. Gordon D.W., Rosenthal G., Hart J., et al. Chaparral ingestion. the broadening spectrum of liver injury caused by herbal medications. J Am Med Assoc 273 (1995) 489-490
104. Sheikh N.M., Philen R.M., and Love L.A. Chaparral-associated hepatotoxicity. Arch Intern Med 157 (1997) 913-919
105. Food and Drug Administration, FDA. Advice to chaparral users. http://www.fda.gov/bbs/topics/ANSWERS/ANS00456.html Accessed: January 14, 2009
106. Furbee R.B., Barlotta K.S., Allen M.K., et al. Hepatotoxicity associated with herbal products. Clin Lab Med 26 (2006) 227-241
107. Chaparral. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
108. Larrey D., Vial T., Pauwels A., et al. Hepatitis after germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Intern Med 117 (1992) 129-132
109. Mostefa-Kara N., Pauwels A., Pines E., et al. Fatal hepatitis after herbal tea. Lancet 340 (1992) 674
110. Zhou S., Koh H.L., Gao Y., et al. Herbal bioactivation: The good, the bad and the ugly. Life Sci 78 (2004) 935-938
111. Mahady G.B., Low Dog T., Barrett M.L., et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15 (2008) 628-638
112. American mistletoe. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
113. European mistletoe. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
114. Huber R., Barth H., Schmitt-Graff A., et al. Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma. J Altern Complement Med 6 (2000) 305-310
115. Steuer-Vogt M.K., Bonkowsky V., Ambrosch P., et al. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomised controlled clinical trial. Eur J Cancer 37 (2001) 23-31
116. Heinzerling L., von Baehr V., Liebenthal C., et al. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J Clin Immunol 26 (2006) 347-359
117. Timoshenko A.V., Cherenkevich S.N., and Gabius H.J. Viscum album agglutinin-induced aggregation of blood cells and the lectin effects on neutrophil function. Biomed Pharmacother 49 (1995) 153-158
118. Grossarth-Matichek R., Kiene H., Baumgartner S.M., et al. Use of iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 7 (2001) 57-58
119. Schoffski P., Breidenbach I., Krauter J., et al. Weekly 24 h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours. Eur J Cancer 41 (2005) 1431-1438
120. Pennyroyal. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
121. Anderson I.B., Mullen W.H., Meeker J.E., et al. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 124 (1996) 726-734
122. Mack R.B. Boldly they rode ... into the mouth of hell. pennyroyal oil toxicity. NC Med J 58 (1997) 456-457
123. Sullivan Jr. J.B., Rumack B.H., Thomas Jr. H., et al. Pennyroyal oil poisoning and hepatotoxicity. J Am Med Assoc 242 (1979) 2873-2874
124. Bakerink J.A., Gospe Jr. S.M., Dimand R.J., et al. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 98 (1996) 944-947
125. Kingston R, Foley C. Herbal, traditional, and alternative medicines. In: Shannon MW, Borron SW, Burns MJ, eds. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Elsevier-Saunders, 2007:1077-88, 2007;(Ch. 68):1077-88.
126. Segelman A., Segelman F.P., Karliner J., et al. Sassafras and herb tea-potential health hazards. J Am Med Assoc 236 (1976) 477
127. Ridker P., Ohkuma S., McDermott W.V., et al. Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine containing dietary substances. Gastroenterology 88 (1985) 1050
128. Steenkamp V., Stewart M.J., and Zuckerman M. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines. Ther Drug Monit 22 (2000) 302-306
129. Chojkier M. Hepatic sinusoidal-obstruction syndrome: Toxicity of pyrrolizidine alkaloids. J Hepatol 39 (2003) 437-446
130. Wadleigh M., Ho V., Momtaz P., et al. Hepatic veno-occlusive disease: Pathogenesis, diagnosis and treatment. Curr Opin Hematol 10 (2003) 451-462
131. Bladderwrack. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 11, 2008
132. Teas J., Pino S., Critchley A., et al. Variability of iodine content in common commercially available edible seaweeds. Thyroidology 14 (2004) 836-841
133. Baker D.H. Iodine toxicity and its amelioration. Exp Biol Med 229 (2004) 473-478
134. Pye K.G., Kelsey S.M., House I.M., et al. Severe dyserythropoeisis and autoimmune thrombocytopenia associated with ingestion of kelp supplement. Lancet 339 (1992) 1540
135. Skibola C.F. The effect of fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: A case report. BMC Complement Altern Med 4 (2004) 10
136. Shilo S., and Hirsch H.J. Iodine induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad Med J 62 (1986) 661-662
137. Shintani S., Murase H., Tsukagoshi H., et al. Glycyrrhizin (licorice) induced hypokalemic myopathy: Report of 2 cases and review of the literature. Eur Neurol 32 (1992) 44-51
138. Maliacal P.P., and Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol 53 (2001) 1323-1329
139. Aloe. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 11, 2008
140. Wilkinson J.M. Effect of ginger tea on the fetal development of Sprague-Daley rats. Reprod Toxicol 14 (2000) 507-512
141. Marcus D., and Snodgrass W.R. Do no harm: Avoidance of herbal medicines during pregnancy. Obstet Gynecol 105 (2005) 1119-1122
142. Banerjee S., Sharma R., Kale R.K., et al. Influence of certain essential oils on carcinogen metabolizing enzymes and acid soluble sulfhydryls in mouse liver. Nutr Cancer 21 (1994) 263-269
143. Miyoshi N., Nakamura Y., Ueda Y., et al. Dietary ginger constituents, galanals A and B, are potent apoptosis in human T lymphoma Jurkat cells. Cancer Lett 199 (2003) 113-119
144. Backgon J. Ginger in preventing nausea and vomiting of pregnancy: A caveat due to its thromboxane synthetase activity and effect on testosterone binding. Eur J Obstet Gynecol Reprod Bio 42 (1991) 163-164
145. Kuichi F., Iwakami S., Shibuya M., et al. Inhibition of prostaglandin and leukotriene synthesis by ginerols and diarylheptanoids. Chem Pharm Bull 40 (1992) 387-391
146. Garlic. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 11, 2008
147. St John's Wort. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
148. Chuang C.H., Doyle P., Wang J.D., et al. Herbal medicines used during the first trimester and major congenital malformations: An analysis of data from a pregnancy cohort study. Drug Saf 29 (2006) 537-548
149. Heinrich M. Ethnobotany and natural products: The search for new molecules, new treatments of old diseases or a better understanding of indigenous cultures. Curr Top Med Chem 3 (2003) 141-154
150. Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines-A systematic review. Acta Psychiatr Scand 108 (2003) 83-91
151. Ginseng P. Natural medicines database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 2, 2008
152. Tamaoki J., Nakata J., Kawatani K., et al. Ginsenoside-induced relaxation of human bronchial smooth muscle via release of nitric oxide. Br J Pharmacol 130 (2000) 1859-1864
153. Keum Y.S., Park K.K., Lee J.M., et al. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 150 (2000) 41-48
154. Moon J., Yu S.J., Kim H.S., and Sohn J. Induction of G(1) cell cycle arrest and p27(K 1) increase by panaxydol isolated from Panax ginseng. Biochem Pharmacol 59 (2000) 1109-1116
155. Kim S.H., and Park K.S. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Rev 48 (2003) 511-513
156. Sievenpiper J.L., Arnason J.T., Leiter L.A., et al. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: The role of ginsenosides. J Am Coll Nutr 23 (2004) 248-258
157. Vuksan V., Stavro M.P., Sievenpiper J.L., et al. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23 (2000) 1221-1226
158. Pan S.J., Ding Z., and Ivy J.L. Ginseng's effects on glucose tolerance and mRNA profiles in a animal model of type II diabetes. Altern Ther Health Med 7 (2001) S26
159. Gonzalez-Seijo J.C., Ramos Y.M., and Lastra I. Manic episode and ginseng: Report of a possible case. J Clin Psychopharmacol 15 (1995) 447-448
160. Valerian. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
161. Klepser T.B., and Klepser M.E. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 56 (1999) 125-138
162. Plushner S.L. Valerian: Valerian officinalis. Am J Health Syst Pharm 57 328 (2000) 333-335
163. Eadie M.J. Could valerian have been the first anticonvulsant?. Epilepsia 45 (2004) 1338-1343
164. Yuan C.S., Mehendale S., Xiao Y., et al. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 98 (2004) 353-358
165. Fernandez S., Wasowski C., Paladini A.C., et al. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. Pharmacol Biochem Behav 77 (2004) 399-404
166. Willey L.B., Mady S.P., Cobaugh D.J., et al. Valerian overdose: A case report. Vet Hum Toxicol 37 (1995) 364-365
167. Garges H.P., Varia I., and Doraiswamy P.M. Cardiac complications and delirium associated with valerian root withdrawal. [Letter to the editor] J Am Med Assoc 280 (1998) 1566-1567
168. Jimson weed. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
169. Hassell L.H., and MacMillan M.W. Acute anticholinergic syndrome following ingestion of angel's trumpet tea. Hawaii Med J 54 (1995) 669-670
170. Passionflower. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
171. Dhawan K., Kumar S., and Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol 78 (2001) 165-170
172. Aoyagi N., Kimura R., and Murata T. Studies on Passiflora incarnata dry extract. I. Isolation of maltol and pharmacological action of maltol and ethyl maltol. Chem Pharm Bull 22 (1974) 1008-1013
173. Salgueiro J.B., Ardenghi P., Dias M., et al. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav 58 (1997) 887-891
174. Akhondzadeh S., Naghavi H.R., Shayeganpour A., et al. Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 26 (2001) 363-367
175. Fisher A.A., Purcell P., and Le Couteur D.G. Toxicity of Passiflora incarnata L. J Toxicol Clin Toxicol 38 (2000) 63-66
176. Eucalyptus. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
177. Gray A.M., and Flatt P.R. Antihyperglycemic actions of Eucalyptus globulus (Eucalyptus) are associated with pancreatic and extra-pancreatic effects in mice. J Nutr 128 (1998) 2319-2323
178. Silva J., Abebe W., Sousa S.M., et al. Analgesic and anti-inflammatory effects of essential oils of eucalyptus. J Ethnopharmacol 89 (2003) 277-283
179. Juergens U.R., Dethlefsen U., Steinkamp G., et al. Anti-inflammatory activity of 1,8-cineol (eucalyptol) in bronchial asthma: A double-blind placebo-controlled trial. Respir Med 97 (2003) 250-256
180. Burkhard P.R., Burkhardt K., Haenggeli C.A., et al. Plant-induced seizures: Reappearance of an old problem. J Neurol 246 (1999) 667-670
181. Darben T., Cominos B., and Lee C.T. Topical eucalyptus oil poisoning. Australas J Dermatol 39 (1998) 265-267
182. Linde K., Ramirez G., Mulrow C.D., et al. St. John's wort for depression: An overview and meta-analysis of randomized clinical trials. BMJ 313 (1996) 253-258
183. Philipp M., Kohnen R., and Hiller K.O. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicenter study of treatment for eight weeks. BMJ 319 (1999) 1534-1539
184. Gaster B., and Holroyd J. St. John's wort for depression. Arch Intern Med 160 (2000) 152-156
185. Williams J.W., Mulrow C.D., Chiquette E., et al. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary. Ann Intern Med 132 (2000) 743-756
186. Schrader E. Equivalence of St. John's wort extract (ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 15 (2000) 61-68
187. Brenner R., Azbel V., Madhusoodanan S., et al. Comparison of an extract of Hypericum (li 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study. Clin Ther 22 (2000) 411-419
188. Szegedi A., Kohnen R., Dienel A., et al. Acute treatment of moderate to severe depression with Hypericum extract WS 5570 (St. John's wort): Randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 330 (2005) 503
189. Shelton R.C. St. John's wort for the treatment of depression. Lancet Neurol 1 (2002) 275
190. Snow V., Lascher S., and Mottur-Pilson C. Pharmacologic treatment of acute major depression and Dysthymia. Ann Intern Med 132 (2000) 738-742
191. Shelton R.C., Keller M.B., Gelenberg A., et al. Effectiveness of St. John's wort in major depression: A randomized, placebo-controlled trial. J Am Med Assoc 285 (2001) 1978-1986
192. de los Reyes G.C., and Koda R.T. Determining hyperforin and hypericin content in eight brands of St. John's wort. Am J Health Syst Pharm 59 (2002) 545-547
193. Calapai G., Crupi A., Firenzuoli F., et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum. Pharmacopsychiatry 34 (2001) 45-49
194. Schule C., Baghai T., Ferrera A., et al. Neuroendocrine effects of Hypericum extract WS 5570 in 12 healthy male volunteers. Pharmacopsychiatry 34 (2001) S127-S133
195. Jensen A.G., Hansen S.H., and Nielsen E.O. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. Life Sci 68 (2001) 1593-1605
196. Jakovljevic V., Popovic M., Mimica-Dukic N., et al. Pharmacodynamic study of Hypericum perforatum L. Phytomedicine 7 (2000) 449-453
197. Schempp C.M., Kirkin V., Simon-Haarhaus B., et al. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 21 (2002) 1242-1250
198. Southwell I.A., and Bourke C.A. Seasonal variation in hypericin content of Hypericum perforatum L. (St. John's wort). Phytochemistry 56 (2001) 437-441
199. Bilia A.R., Bergonzi M.C., Morgenni F., et al. Evaluation of chemical stability of St. John's wort commercial extract and some preparations. Int J Pharm 213 (2001) 199-208
200. Hubner W.D., and Kirste T. Experience with St. John's wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res 15 (2001) 367-370
201. Brown T.M. Acute St. John's wort toxicity. Am J Emerg Med 18 (2000) 231-232
202. Patel S., Robinson R., and Burk M. Hypertensive crisis associated with St. John's wort. Am J Med 112 (2002) 507-508
203. Beckman S.E., Sommi R.W., and Switzer J. Consumer use of St. John's wort: A survey of effectiveness, safety, and tolerability. Pharmacotherapy 20 (2000) 568-574
204. Dean A.J., Moses G.M., and Vernon J.M. Suspected withdrawal syndrome after cessation of St. John's wort. Ann Pharmacother 37 (2003) 150
205. Nutmeg. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
206. Sangalli B.C., and Chiang W. Toxicology of nutmeg abuse. Clin Toxicol 38 (2000) 671-678
207. Mueller S.C., Majcher-Peszynska J., Uehleke B., et al. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 62 (2006) 29-36
208. Weiss J., Sauer A., Frank A., et al. Extracts and kavalactones of piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab Dispos 33 (2005) 1580-1583
209. Gurley B.J., Swain A., Barone G.W., et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 35 (2007) 240-245
210. Johne A., Brockmoller J., Bauer S., et al. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 66 (1999) 338-345
211. Durr D., Stieger B., Kullak-Ublick G.A., et al. St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68 (2000) 598-604
212. Hennessy M., Kelleher D., Spiers J.P., et al. St. John's wort increases expression of P-glycoprotein: Implications for drug interactions. Br J Clin Pharmacol 53 (2002) 75-82
213. Kim R.B. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev 34 (2002) 47-54
214. Red clover. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
215. Saw Palmetto. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
216. Comfrey. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
217. Feverfew. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
218. Evening primrose oil. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
219. Echinacea. Natural Medicines Database. Therapeutic Research Faculty. Stockton, CA. http://www.naturaldatabase.com/(S(qku2mt55awj5j4iammokfc45))/home.aspx?cs=&s=ND Accessed January 15, 2008
220. Fugh-Berman A. Herb-drug interactions. Lancet 355 (2000) 134-138
221. Ernst E. Harmless herbs?. A review of the recent literature. Am J Med 104 (1998) 170-178
222. Castot A., and Larrey D. Hepatitis observed during a treatment with a drug or tea containing wild germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterologie Clin Biol 16 (1992) 916-922
223. Haller C., Anderson I.B., Kim S.Y., et al. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events Adverse Drug React. Toxicol Rev 21 (2002) 143-150